{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:29:52Z","timestamp":1770719392406,"version":"3.49.0"},"reference-count":22,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T00:00:00Z","timestamp":1194912000000},"content-version":"vor","delay-in-days":3695,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1997,10]]},"abstract":"<jats:p>A 6\u2010week, double\u2010blind, randomized, multicentre, parallel\u2010group study was conducted to compare the efficacy of quetiapine (\u201cSeroquel\u201d) (<jats:italic>n<\/jats:italic>=101) with that of chlorpromazine (n=100) in hospitalized patients with acute exacerbation of subchronic or chronic schizophrenia, or schizophreniform disorder. The tolerabilities of the two treatments were also compared. The mean daily doses of quetiapine and chlorpromazine at the end of the study were 407 mg and 384 mg, respectively. Both treatments were effective in the treatment of positive and negative symptoms, with a trend towards superior efficacy for quetiapine. The quetiapine group had a lower incidence of adverse events than the chlorpromazine group, and a low incidence of treatment\u2010emergent extrapyramidal symptoms. Quetiapine was not associated with a sustained increase in serum prolactin. These clinical data support the preclinical profile of quetiapine as an atypical antipsychotic agent.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1997.tb10162.x","type":"journal-article","created":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T17:25:27Z","timestamp":1194974727000},"page":"265-273","source":"Crossref","is-referenced-by-count":185,"title":["A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia"],"prefix":"10.1111","volume":"96","author":[{"given":"J.","family":"Peuskens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. G. G.","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11,13]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00606409"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199040050-00007"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1192\/S0007125000296876","article-title":"The importance of serotonin\u2010dopamine interactions in the action of clozapine","volume":"160","author":"Meltzer H.","year":"1992","journal-title":"Br J Psychiatry"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244923"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(75)90482-8"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1523\/JNEUROSCI.03-08-01607.1983","article-title":"Typical and atypical antipsychotics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons","volume":"3","author":"Chiodo LA","year":"1983","journal-title":"Neuroscience"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1126\/science.6136093","article-title":"Differential aspects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons","volume":"221","author":"White FJ","year":"1983","journal-title":"Science"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244924"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00442559"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244925"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-9964(93)90525-N"},{"key":"e_1_2_1_14_2","first-page":"000","article-title":"Seroquel, a new atypical antipsychotic drug","volume":"00","author":"Hirsch SR","year":"1996","journal-title":"Br J Psychiatry"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0149-2918(95)80102-2"},{"key":"e_1_2_1_16_2","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1987"},{"key":"e_1_2_1_17_2","first-page":"158","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Overall JE","year":"1976"},{"key":"e_1_2_1_18_2","first-page":"218","volume-title":"ECDEU assessment manual for psychopharmacology, revised edn","author":"CGI: Clinical Global Impression","year":"1976"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800250095013"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"e_1_2_1_22_2","first-page":"158","volume-title":"ECDEU assessment manual for psychopharmacology","author":"AIMS: Abnormal Involuntary Movement Scale","year":"1976"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1997.tb10162.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1997.tb10162.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:40:55Z","timestamp":1698403255000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1997.tb10162.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1111\/j.1600-0447.1997.tb10162.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1997.tb10162.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}